Manual of clinical psychopharmacology
著者
書誌事項
Manual of clinical psychopharmacology
American Psychiatric Pub., c2015
8th ed
- : pbk
大学図書館所蔵 全2件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Standard of care in psychiatry requires that practitioners stay current on new agents, interactions, side effects, and dosing guidelines-a daunting task for the modern clinician grappling with today's challenging medical environment. The Manual of Clinical Psychopharmacology has been the psychiatrist's trusted companion for nearly three decades, and this new, eighth edition delivers the cutting-edge information clinicians need in a down-to-earth style, facilitating the integration of biological and psychopharmacological information into practice. The book's primary purpose is to provide the reader-practitioner with a practical, usable clinical guide to the selection and prescription of appropriate drug therapies for individual patients, drawing on the authors' clinical experience as well as on the scientific literature. Students of psychiatry and psychopharmacology also will find the book useful as both text and reference.
The eighth edition retains many of its most popular features, while adding others to enhance coverage and promote comprehension: * Some sections dealing with less commonly used drugs (e.g., barbiturates) have been shortened or eliminated, making space for the huge number of new agents that have been approved (e.g., vortioxetine) or are likely to receive approval from the U.S. Food and Drug Administration (FDA). This makes the volume easier to use. * The book has been thoroughly updated to reflect the release of DSM-5, which introduced dimensional measures of key dimensions (e.g., anxiety and depression) across diagnostic categories to better describe patients' disorders. In the chapter on diagnosis and classification, the authors review these major changes and the implications for prescribing.* Features of particular utility for students include the introductory chapter on the general principles of psychopharmacological treatment and the summary medication tables, which serve as quick-reference guides on classes of psychotropics.* Although largely evidence-based, the authors also draw on their extensive clinical experience in discussing various drugs' efficacy, dosing and side effects and other important factors. * Two appendixes offer suggested readings for clinicians and for patients and families, as well as information on strengths and costs of antidepressant and antipsychotic drugs. There has never been a more meticulously researched and referenced guide to prescribing psychotropic medications, nor one more down-to-earth and practical. The Manual of Clinical Psychopharmacology richly deserves its reputation as a classic in the field and has earned a place on every psychiatrist's desk.
目次
PrefaceDisclosure of Competing InterestsChapter 1. General Principles of PsychopharmacologicalChapter 2. Diagnosis and ClassificationChapter 3. AntidepressantsChapter 4. Antipsychotic DrugsChapter 5. Mood StabilizersChapter 6. Antianxiety AgentsChapter 7. HypnoticsChapter 8. Stimulants and Other Fast-Acting DrugsChapter 9. Augmentation Strategies for Treatment-Resistant DisordersChapter 10. Emergency Department TreatmentChapter 11. Pharmacotherapy for Substance Use DisordersChapter 12. Pharmacotherapy in Special SituationsAppendix: Suggested ReadingsIndex
「Nielsen BookData」 より